US FDA finalizes expedited access pathway for devices addressing unmet medical needs
This article was originally published in SRA
Executive Summary
The US Food and Drug Administration has finalized a new, voluntary program to that aims to speed up the regulatory evaluation of medical devices that can potentially address unmet medical needs for life threatening or irreversibly debilitating diseases1.